Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug
Clinical trial NCT06641076 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06641076
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2027-02-04
- Enrollment
- 960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.